| Cellectis In-licenses Induced Pluripotent Stem Cell Technology from iPS Academia Japan | ||||
|
|
Signing of two separate non-exclusive agreements grants Cellectis worldwide access to the induced Pluripotent Stem cells patent portfolio.
Διαβάστε ολόκληρο το άρθρο στο StemCells.net
|
